Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Current Leases: 2022-2025

Historic Current Leases for Biofrontera (BFRI) over the last 3 years, with Sep 2025 value amounting to $307,000.

  • Biofrontera's Current Leases fell 54.18% to $307,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $307,000, marking a year-over-year decrease of 54.18%. This contributed to the annual value of $548,000 for FY2024, which is 20.69% down from last year.
  • Per Biofrontera's latest filing, its Current Leases stood at $307,000 for Q3 2025, which was down 30.70% from $443,000 recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Current Leases peaked at $701,000 during Q2 2024, and registered a low of $307,000 during Q3 2025.
  • Moreover, its 3-year median value for Current Leases was $551,500 (2023), whereas its average is $551,500.
  • As far as peak fluctuations go, Biofrontera's Current Leases spiked by 42.56% in 2024, and later plummeted by 54.18% in 2025.
  • Quarterly analysis of 4 years shows Biofrontera's Current Leases stood at $498,000 in 2022, then soared by 38.76% to $691,000 in 2023, then dropped by 20.69% to $548,000 in 2024, then crashed by 54.18% to $307,000 in 2025.
  • Its last three reported values are $307,000 in Q3 2025, $443,000 for Q2 2025, and $426,000 during Q1 2025.